Search Results

There are 125094 results for: content related to: The perils with the misuse of predictive power

  1. The role of the minimum clinically important difference and its impact on designing a trial

    Pharmaceutical Statistics

    Volume 10, Issue 3, May/June 2011, Pages: 250–256, Christy Chuang-Stein, Simon Kirby, Ian Hirsch and Gary Atkinson

    Article first published online : 8 OCT 2010, DOI: 10.1002/pst.459

  2. The effect of variability and carryover on average bioequivalence assessment: A simulation study

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 135–142, María Pilar Sánchez O, Jordi Ocaña and Josep L. Carrasco

    Article first published online : 20 APR 2010, DOI: 10.1002/pst.431

  3. You have full text access to this OnlineOpen article
    Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 150–161, Peter C. Austin

    Article first published online : 27 APR 2010, DOI: 10.1002/pst.433

  4. Effects of unstratified and centre-stratified randomization in multi-centre clinical trials

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 50–59, Vladimir V. Anisimov

    Article first published online : 28 JAN 2010, DOI: 10.1002/pst.412

  5. An optimal adaptive design to address local regulations in global clinical trials

    Pharmaceutical Statistics

    Volume 9, Issue 3, July/September 2010, Pages: 179–189, Xiaolong Luo, Weichung Joe Shih, S. Peter Ouyang and Robert J. DeLap

    Article first published online : 22 SEP 2010, DOI: 10.1002/pst.456

  6. Confirmatory analysis for phase III population pharmacokinetics

    Pharmaceutical Statistics

    Volume 10, Issue 1, January/February 2011, Pages: 14–26, Chuanpu Hu, Ji Zhang and Honghui Zhou

    Article first published online : 29 DEC 2009, DOI: 10.1002/pst.403

  7. An alternative phase II/III design for continuous endpoints

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 105–114, Wong-Shian Huang, Jen-pei Liu and Chin-Fu Hsiao

    Article first published online : 22 FEB 2010, DOI: 10.1002/pst.418

  8. Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation

    Pharmaceutical Statistics

    Volume 10, Issue 3, May/June 2011, Pages: 265–276, Robert Schall and Arne Ring

    Article first published online : 26 OCT 2010, DOI: 10.1002/pst.463

  9. Sample size and proportion of Japanese patients in multi-regional trials

    Pharmaceutical Statistics

    Volume 9, Issue 3, July/September 2010, Pages: 207–216, Kimitoshi Ikeda and Frank Bretz

    Article first published online : 22 SEP 2010, DOI: 10.1002/pst.455

  10. Increasing the sample size at interim for a two-sample experiment without Type I error inflation

    Pharmaceutical Statistics

    Volume 9, Issue 4, October/December 2010, Pages: 280–287, Keith Dunnigan and Dennis W. King

    Article first published online : 17 SEP 2009, DOI: 10.1002/pst.390

  11. Assessing departure from dose linearity under a repeated measures incomplete block design

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 357–362, Bin Cheng and Shein-Chung Chow

    Article first published online : 22 NOV 2010, DOI: 10.1002/pst.474

  12. A new mathematical approach for the estimation of the AUC and its variability under different experimental designs in preclinical studies

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Pages: 14–23, Carmen Navarro-Fontestad, Isabel González-Álvarez, Carlos Fernández-Teruel, Marival Bermejo and Vicente Germán Casabó

    Article first published online : 25 JAN 2011, DOI: 10.1002/pst.484

  13. Issues for stratified randomization based on a factor derived from a continuous baseline variable

    Pharmaceutical Statistics

    Volume 10, Issue 3, May/June 2011, Pages: 232–235, Yongming Qu

    Article first published online : 4 OCT 2010, DOI: 10.1002/pst.453

  14. Assessing non-inferiority to an aggregate response with an application to development of pneumococcal conjugate vaccines

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 332–340, Yi Pan, Guanghan F. Liu and Michael J. Dallas

    Article first published online : 9 NOV 2010, DOI: 10.1002/pst.470

  15. Sample size re-estimation for survival data in clinical trials with an adaptive design

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 325–331, Kanae Togo and Manabu Iwasaki

    Article first published online : 28 OCT 2010, DOI: 10.1002/pst.469

  16. Block response-adaptive randomization in clinical trials with binary endpoints

    Pharmaceutical Statistics

    Volume 10, Issue 4, July/August 2011, Pages: 341–346, Dominic Magirr

    Article first published online : 9 NOV 2010, DOI: 10.1002/pst.471

  17. Adapting by calibration the sample size of a phase III trial on the basis of phase II data

    Pharmaceutical Statistics

    Volume 10, Issue 2, March/April 2011, Pages: 89–95, Daniele De Martini

    Article first published online : 8 FEB 2010, DOI: 10.1002/pst.410

  18. Sample-size calculations for multi-group comparison in population pharmacokinetic experiments

    Pharmaceutical Statistics

    Volume 9, Issue 4, October/December 2010, Pages: 255–268, Kayode Ogungbenro and Leon Aarons

    Article first published online : 27 AUG 2009, DOI: 10.1002/pst.388

  19. Estimation of the limit of detection for quantal response bioassays

    Pharmaceutical Statistics

    Volume 10, Issue 3, May/June 2011, Pages: 203–212, Edwin van den Heuvel

    Article first published online : 4 MAY 2010, DOI: 10.1002/pst.435

  20. Investigating the assumption of homogeneity of treatment effects in clinical studies with application to meta-analysis

    Pharmaceutical Statistics

    Volume 11, Issue 1, January/February 2012, Pages: 49–56, Steven A. Julious and Anne Whitehead

    Article first published online : 2 DEC 2011, DOI: 10.1002/pst.494